“Safety of Tralokinumab for the Treatment of Atopic Dermatitis in Patients With Up to 4.5 Years of Treatment: An Updated Integrated Analysis of Eight Clinical Trials ”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 2, Mar. 2024, p. s375, https://doi.org/10.25251/skin.8.supp.375.